Effectiveness and Prognostic Factors of Everolimus in Patients with Pancreatic Neuroendocrine Neoplasms

OBJECTIVE: The effectiveness of everolimus for the management of pancreatic neuroendocrine neoplasms (PNENs), including the G3/NEC types, remains unclear. We therefore investigated the effectiveness of the drug for the management of PNENs. METHODS: We analyzed the progression-free survival (PFS) and...

Descripción completa

Detalles Bibliográficos
Autores principales: Kurita, Yusuke, Kobayashi, Noritoshi, Hara, Kazuo, Mizuno, Nobumasa, Kuwahara, Takamichi, Okuno, Nozomi, Haba, Shin, Tokuhisa, Motohiko, Hasegawa, Sho, Sato, Takamitsu, Hosono, Kunihiro, Kato, Shingo, Kessoku, Takaomi, Endo, Itaru, Shimizu, Yasuhiro, Kubota, Kensuke, Nakajima, Atsushi, Ichikawa, Yasushi, Niwa, Yasumasa
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Japanese Society of Internal Medicine 2022
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9908390/
https://www.ncbi.nlm.nih.gov/pubmed/35705270
http://dx.doi.org/10.2169/internalmedicine.9416-22

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9908390/
https://www.ncbi.nlm.nih.gov/pubmed/35705270
http://dx.doi.org/10.2169/internalmedicine.9416-22

Ejemplares similares